National HealthCare Corporation (NHC) Fair Value & Analysis
Healthcare · US · Market cap $2.9B
National HealthCare Corporation
NHC · US
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from $166.97 to $168.98 (+1.2%) since Jun 23, 2026. Share price +11.9% over the past month.
Price vs Fair Value (12 months)
12‑month range $90.12 – $199.74 · fair‑value band $113.64 – $211.30 · the $199.54 price screens above the $168.98 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
National HealthCare Corporation (NHC) currently trades at $199.54, while our model-based Fair Value estimate is $168.98 — implying the stock looks roughly 15.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, National HealthCare Corporation generated revenue of $1.5B at a net margin of 8.1%. Revenue grew 2.2% year over year. It earns a return on equity of 12.0%. The balance sheet holds a net cash position of $23.9M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. It provides medical specialty units comprise memory care units and sub-acute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
National HealthCare Corporation reported revenue of $1.5B in FY2025 versus $1.0B in FY2021, a compound +10.6%/yr. Reported net income was $120M in FY2025, compounding −3.5%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is National HealthCare Corporation (NHC) undervalued?
What is the fair value of NHC?
What is the quality score of NHC?
What is the revenue of National HealthCare Corporation (NHC)?
What is the net profit margin of NHC?
Does National HealthCare Corporation pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.